Allen H Christine, Garbe M Connor, Lees Julie, Aziz Naila, Chaaban Hala, Miller Jamie L, Johnson Peter, DeLeon Stephanie
Department of Pediatrics: Section of Pediatric Critical Care, University of Oklahoma College of Medicine, Oklahoma City, OK.
Department of Pediatrics: Section of General and Community Pediatrics, University of Oklahoma College of Medicine, Oklahoma City, OK.
J Okla State Med Assoc. 2018 Oct;111(8):776-783.
Clinician prescribing of off-label medications is common due to a lack of pediatric-specific data regarding the dosing, efficacy and safety of medications regularly prescribed to children.
This systematic review summarizes the published incidence of off-label medication use in children from the past 10 years. We also performed a retrospective chart review to determine the incidence of off-label prescriptions for children seen in the OU Physicians clinics.
We conducted a literature search of PubMed and OVID Medline from 2007 to 2017. Search terms included off-label use of medications and all child. For the local review, the outpatient electronic medical record (EMR) was queried.
Studies were eligible for inclusion if the study included children < 18 years of age, defined off-label use in the paper, and included the incidence of off-label drug use.
Each review author extracted the study data from their assigned studies. For the retrospective chart review, the EMR was queried for patients <21 years of age who had a clinic visit and received a new prescription during 2017.
We identified 31 studies, with off-label prescription rates from 3.2 % to 95%. The local retrospective chart review included 1,323 prescriptions; 504 were off-label (38.1%) and 819 were approved. The frequency of off-label prescriptions does not differ significantly between the meta-analysis from the systematic review and the local retrospective chart review (30.9% vs 38.1%).
The use of off-label medications in children remains a common practice for pediatric providers.
由于缺乏针对儿童定期使用药物的剂量、疗效和安全性的儿科特定数据,临床医生开具非标签药物的情况很常见。
本系统评价总结了过去10年中已发表的儿童使用非标签药物的发生率。我们还进行了一项回顾性病历审查,以确定在俄克拉荷马大学医师诊所就诊的儿童的非标签处方发生率。
我们对2007年至2017年的PubMed和OVID Medline进行了文献检索。检索词包括药物的非标签使用和所有儿童。对于本地审查,查询了门诊电子病历(EMR)。
如果研究包括18岁以下儿童、在论文中定义了非标签使用且包括非标签药物使用的发生率,则该研究符合纳入条件。
每位综述作者从他们分配的研究中提取研究数据。对于回顾性病历审查,查询了2017年期间就诊并接受新处方的21岁以下患者的EMR。
我们确定了31项研究,非标签处方率从3.2%到95%不等。本地回顾性病历审查包括1323份处方;504份为非标签处方(38.1%),819份为批准处方。系统评价的荟萃分析与本地回顾性病历审查之间的非标签处方频率没有显著差异(30.9%对38.1%)。
儿科医疗服务提供者使用非标签药物仍然是一种常见做法。